Content related to Chemotherapy and Hearing Loss: Until Now, an Unquantified Risk

A CHLA oncologist led a pivotal clinical trial leading to the approval of the first drug to prevent cisplatin hearing loss in children.

Investigators from Children’s Hospital Los Angeles and 37 other Children’s Oncology Group hospitals in the U.S. and Canada have determined that sodium thiosulfate prevents cisplatin-induced hearing

Investigators at Children’s Hospital Los Angeles have found that chemotherapy-induced hearing loss may also contribute to long-term neurocognitive deficits in pediatric brain tumor survivors.

Researchers have been delving deeper to better understand long-term cancer survival and quality of life for adolescent and young adult patients.

The novel cancer drugs often grab the headlines. But Dr. Orgel's research has a different focus: making current treatments better—and less toxic.

In the News - Awards and Honors - New Faces

A new study reveals the value of using clinical and histological characteristics to optimize treatment for hepatoblastoma, a rare liver cancer in children.

Patients with acute lymphoblastic leukemia are at increased risk for bone fractures due to bone loss resulting from treatment. This decrease in bone density (as illustrated here) can occur as soon as